Zacks Investment Research on MSN
RMD stock set to gain from FDA clearance of AI-enabled smart comfort
Resmed RMD has received FDA clearance for Personalized Therapy Comfort Settings (“PTCS”), which will be marketed as Smart Comfort. The company will debut Smart Comfort in early 2026 in a limited U.S.
Background: Online support communities have become an accessible way of gaining social, emotional, and informational support from peers and may be particularly useful for individuals with chronic ...
Resmed is looking to new innovations to give the sleep health company an advantage against its competitors. The company, which makes sleep apnea machines, masks and accessories, highlighted new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback